CCHT Legal and Regulatory Compliance 2 — Questions and Answers

Question 1: Which federal agency sets the Conditions for Coverage (CfC) that dialysis facilities must meet to receive Medicare reimbursement?

The Food and Drug Administration (FDA)
The Centers for Medicare & Medicaid Services (CMS) (Correct answer)
The Occupational Safety and Health Administration (OSHA)
The Joint Commission (TJC)

Correct answer: The Centers for Medicare & Medicaid Services (CMS)

CMS establishes the Conditions for Coverage (CfC) for ESRD facilities, which are the minimum health and safety standards facilities must meet to participate in the Medicare program. CMS conducts or oversees surveys to verify compliance.

The Centers for Medicare & Medicaid Services (CMS), a division of the U.S. Department of Health and Human Services, administers the Medicare ESRD Program, which covers approximately 90% of ESRD patients in the United States. CMS established the Conditions for Coverage (CfC) for ESRD Facilities in 2008 (42 CFR Part 494), replacing the older Conditions of Participation from 1976. The CfC are organized around key areas: patient rights, patient assessment, care planning, dialysis adequacy, water and dialysate quality, reuse of hemodialyzers, infection control, patient education and training, physical environment, and administrative requirements. They represent the minimum standards; many facilities implement higher standards through accreditation bodies. CMS conducts surveys of dialysis facilities through state survey agencies (every 3 years for routine surveys, more frequently if complaints are received or deficiencies identified). Facilities found out of compliance receive a Form CMS-2567 listing deficiencies and must submit a Plan of Correction. Serious deficiencies can result in termination from Medicare, imposition of civil monetary penalties, or appointment of temporary management. The FDA regulates dialysis equipment (as medical devices) and dialysate concentrate (as a drug). OSHA sets workplace safety standards for dialysis staff (bloodborne pathogen exposure, chemical hazards). TJC is a voluntary accreditation organization that surveys dialysis facilities for some health systems. Understanding the distinct roles of each agency is important for CCHT exam preparation.

Question 2: A dialysis patient asks to see their own medical records. Under HIPAA, how should the facility respond?

Deny the request as medical records contain technical information patients cannot understand
Provide access within 30 days (or 60 days with one 30-day extension) at a reasonable cost (Correct answer)
Refer the patient to their nephrologist to obtain records through the physician's office
Provide verbal summary only; written records cannot be given directly to patients

Correct answer: Provide access within 30 days (or 60 days with one 30-day extension) at a reasonable cost

Under the HIPAA Privacy Rule, patients have the right to access their own protected health information (PHI), including medical records. Facilities must respond within 30 days (extendable to 60 days with notice) and may charge a reasonable cost-based fee for copying records.

The HIPAA Privacy Rule (45 CFR §164.524) grants individuals the right to access, inspect, and obtain copies of their own designated record set, which includes the medical record, billing records, and any other records used to make decisions about the patient's care. Facilities must honor patient access requests within 30 calendar days of receiving the request. If additional time is needed (e.g., records are stored offsite), the facility may extend the deadline by one additional 30-day period if the patient is notified in writing of the reason for delay and the expected completion date. Only one extension is permitted per request. Facilities may charge a reasonable cost-based fee for copies (paper or electronic), but may not charge for the time spent retrieving or locating the records. Electronic records must be provided in the format requested by the patient (if the format is readily producible) or in a readable electronic format. The facility may only deny access in limited circumstances: psychotherapy notes, information compiled in anticipation of civil/criminal litigation, or information that a licensed healthcare professional has documented would likely cause substantial harm to the patient or another person. These denials are subject to review by a licensed healthcare professional not involved in the original decision. The patient has the right to have the denial reviewed. All dialysis facility staff must complete HIPAA training and understand their obligations regarding patient information privacy and access rights.

Question 3: What is the role of the ESRD Network Organization in dialysis quality oversight?

They directly employ dialysis technicians and set their wages
They provide quality improvement assistance and patient grievance services under a CMS contract (Correct answer)
They perform annual licensing inspections of all dialysis facilities
They process Medicare claims and approve treatment orders

Correct answer: They provide quality improvement assistance and patient grievance services under a CMS contract

ESRD Network Organizations are nonprofit organizations under contract with CMS that provide quality improvement support to dialysis facilities and serve as a patient grievance resource. They collect outcome data, assist facilities with quality improvement projects, and can investigate patient complaints.

There are 18 ESRD Network Organizations across the United States, each covering a geographic region. They operate under contracts with CMS and serve several critical functions in the ESRD quality ecosystem. Key Network functions include: collecting and analyzing clinical outcome data from all dialysis facilities in their region (through CROWNWeb, the national ESRD data system); providing quality improvement technical assistance to facilities with below-average outcomes on metrics such as Kt/V adequacy, hemoglobin management, and vascular access; serving as the first-line recipient of patient grievances from dialysis patients who believe their rights have been violated or their care was inadequate; and investigating serious patient safety events in facilities. Patients have the right to file grievances directly with their Network at any time. The Network must investigate and respond to the patient's complaint in a timely manner. If the grievance involves a potential CfC violation, the Network may refer the case to the state survey agency. Networks also manage Emergency Preparedness activities in their region, coordinate care transitions (e.g., patients discharged from dialysis to home, or admitted to hospital), and provide patient education resources. They publish regional and national data through annual reports (ESRD Data Systems, formerly USRDS). Facilities participate in Network quality improvement projects as a CfC requirement. The CCHT should understand that Networks are allies in quality improvement, not punitive inspectors—they provide free education, tools, and technical assistance.

Question 4: Under CMS Conditions for Coverage, what is required regarding informed consent for hemodialysis treatment?

Consent is required only for new procedures or changes to the treatment plan, not for routine dialysis
Informed consent must be documented before initiating treatment, with the patient having the right to refuse or withdraw consent at any time (Correct answer)
Written consent is needed only for patients who are incompetent to consent verbally
Informed consent is the nephrologist's sole responsibility and does not involve dialysis technicians

Correct answer: Informed consent must be documented before initiating treatment, with the patient having the right to refuse or withdraw consent at any time

CMS CfC requires that patients provide informed consent prior to treatment, with documentation in the medical record. Patients retain the right to refuse or withdraw consent at any time, even mid-treatment, with appropriate documentation of the refusal and consequences discussed.

Informed consent is both an ethical principle (patient autonomy) and a legal/regulatory requirement under the CMS ESRD Conditions for Coverage, HIPAA, and state laws. For dialysis patients, informed consent encompasses: the nature and purpose of hemodialysis, expected benefits and potential risks (including immediate complications and long-term effects), alternative treatments (peritoneal dialysis, home hemodialysis, transplant, or conservative management/withdrawal), the right to refuse treatment or withdraw from treatment at any time, and the likely consequences of refusing treatment (including death from uremia). Informed consent for dialysis is typically obtained once at the initiation of dialysis and then updated when there is a significant change in the patient's treatment plan, access modality, or clinical status. The consent form becomes part of the permanent medical record. Verbal consent is documented at each treatment in some facilities, especially for patients who have demonstrated understanding and stability. Patients who wish to discontinue dialysis have the right to do so—this is a legal and ethical right, not simply a request. When a competent patient elects to withdraw from dialysis, the facility must provide: respectful communication, palliative care consultation, explanation of the expected course (life expectancy without dialysis is typically days to weeks depending on residual renal function), and documentation. Facility staff, including the CCHT, must understand that honoring withdrawal of consent is required, not optional. For patients who lack decision-making capacity, consent is obtained from the legally authorized representative (healthcare proxy, durable power of attorney for healthcare, or court-appointed guardian).

Question 5: What is the purpose of the ESRD Quality Incentive Program (QIP)?

To provide financial bonuses to patients who comply with their dialysis schedule
To reduce Medicare payments to dialysis facilities with poor performance on quality measures (Correct answer)
To fund capital improvements in dialysis facilities in rural areas
To establish minimum staffing ratios for hemodialysis units

Correct answer: To reduce Medicare payments to dialysis facilities with poor performance on quality measures

The ESRD Quality Incentive Program (QIP) is a CMS value-based purchasing program that penalizes dialysis facilities with substandard performance on clinical and operational quality measures by reducing their total performance score-based Medicare payments by up to 2%.

The ESRD Quality Incentive Program (QIP), established under the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA), was the first value-based purchasing program in Medicare. It was implemented beginning with Payment Year 2012 and has evolved significantly each year with new quality measures added. The QIP calculates a Total Performance Score (TPS) for each dialysis facility based on performance across a set of clinical and reporting quality measures. Clinical measures have historically included: Kt/V adequacy (percentage of patients meeting minimum Kt/V targets), hemoglobin management (avoiding both under- and over-treatment with ESAs), vascular access (fistula prevalence, catheter reduction), hypercalcemia rates, patient experience (CAHPS ESRD survey), and infection reporting. Facilities with TPS below a minimum threshold receive a payment reduction on their Medicare claims for that payment year—up to 2% of total payment. This can represent millions of dollars for large dialysis organizations. No facility receives a bonus; the program only imposes penalties. QIP incentivizes continuous quality improvement by rewarding facilities that achieve either high absolute scores or demonstrate significant improvement from prior years. Facilities receive their TPS and detailed measure-level results annually and must use these to drive quality improvement initiatives. The CCHT contributes to QIP performance through: ensuring Kt/V targets are met (proper blood flow, adequate treatment time), documenting treatments accurately, supporting vascular access care to reduce catheter use, and adhering to infection control protocols that affect infection reporting measures.

Question 6: A dialysis technician witnesses a co-worker falsifying a treatment record by entering a blood flow rate that was not actually achieved. What is the appropriate action?

Correct the record personally to protect patient safety without involving management
Report the falsification to the supervisor or through the facility's compliance reporting mechanism (Correct answer)
Confront the co-worker directly and give them an opportunity to correct the record first
Document the observation in the patient's chart alongside the falsified entry

Correct answer: Report the falsification to the supervisor or through the facility's compliance reporting mechanism

Falsification of medical records is fraud and a serious patient safety issue—inaccurate blood flow rate documentation could mask inadequate dialysis delivery (low Kt/V). The correct action is to report the incident to a supervisor or through the facility's compliance/ethics reporting system.

Medical record falsification is a serious violation that constitutes fraud, carries both civil and criminal penalties, jeopardizes patient safety, and violates professional ethics. In dialysis, accurate documentation of blood flow rates is directly tied to Kt/V calculation and treatment adequacy. If blood flow rate is documented higher than actually achieved, the patient may appear adequately dialyzed when they are not. The appropriate response to observed falsification is not to modify the record personally (which could itself be misinterpreted as tampering), not to directly confront the co-worker (which may escalate the situation, impede investigation, or expose the witness to retaliation), but to promptly report the observation to the charge nurse, supervisor, or facility compliance officer through the established reporting mechanism. Most dialysis organizations have anonymous compliance hotlines (sometimes called 'ethics hotlines' or 'integrity hotlines') specifically for reporting potential fraud, waste, and abuse. Federal law (Qui Tam provisions of the False Claims Act) protects and financially rewards whistleblowers who report Medicare fraud. Retaliating against an employee who reports compliance concerns is itself illegal. The reporter should document what they observed (date, time, patient, co-worker, specific falsification) and maintain a personal record separate from facility records. The CCHT has both an ethical obligation and, in most states, a legal duty to report patient safety violations and healthcare fraud. Failure to report known fraud may implicate the silent observer in the violation.

CCHT Legal and Regulatory Compliance 2

Which federal agency sets the Conditions for Coverage (CfC) that dialysis facilities must meet to receive Medicare reimbursement?